You’re reading the web version of STAT’s Health Tech newsletter. This newsletter is a guide to how technology is transforming the life sciences. Sign up to get it delivered to your inbox every Tuesday and Thursday.
Otsuka Pharmaceutical and Amalgam collaborate on Alzheimer’s disease care technology
You may remember that precision health company Otsuka decided to lower the price and make its digital treatment for depression more accessible, even if it meant losing money, and now it’s making a digital treatment for depression cheaper and more accessible to caregivers of Alzheimer’s patients. We are partnering with Amalgam on the app for The app, called Elevmi, is based on a large-scale language model trained with information from the National Institute on Aging and PsychU, an online mental health site.
Hello Heart joins Amwell’s telemedicine network
Virtual health provider Amwell, whose customers typically include employer-based insurance companies, has signed preventive heart health startup Hello Heart to its clinical program platform. The companies say this means employers who pay Amwell health insurance premiums for their employees can offer Hello Heart accounts to beneficiaries with high blood pressure, high cholesterol or other cardiovascular risk factors. It was announced today.
Biogen uses telemedicine to enhance postpartum depression treatment
In what appears to be the latest partnership between a pharmaceutical company and a tail health company, biotech giant Biogen is partnering with Talkiatry to increase awareness of its postpartum depression drug Zurzvae, my colleagues say. Reported by Mario Aguilar. (Talkiatry recently raised $130 million in venture funding and has a staff of more than 350 psychiatrists.)
Under the partnership, Talkiatry has launched a new landing page on its site aimed at raising awareness about postpartum depression. After undergoing an initial assessment, visitors are directed to the telemedicine company’s care program, and Zurzuvae’s website includes a link to Talkiatry’s landing page. Financial terms of the deal were not disclosed.
This is a similar model to that used by major pharmaceutical companies like Eli Lilly and Pfizer, both of which aim to work with telemedicine companies to make it easier for patients to learn about and access their medicines. are. Read more about Contracts from Mario and what they mean.
What Kaiser Permanente learned from using Apple Watch technology to treat Parkinson’s disease
Mario also delved into Kaiser Permanente’s pilot exploring how the Apple Watch could help keep Parkinson’s patients out of the hospital. Since 2023, the health system has been offering an Apple Watch app called StrivePD to some patients. The app, sold by Rune Labs, uses on-board sensors to track symptoms of tremors and other neurodegenerative diseases and shares that data with patients, their caregivers, and doctors. Read more about what Kaiser clinicians discovered early in the experiment and whether the program is financially sustainable.
The case for a new medical specialty: asynchronous care
In a thought-provoking first opinion, physicians Muthu Alagappan, Rishi Kakhar and Ben Kornitzer argue that doctors no longer have to juggle in-person and online, messaging-based care, but instead focus on We are proposing a completely new model that opens up new fields of expertise. Specifically, it is “asynchronous medical care.”
“Today, the fastest growing healthcare setting is neither the hospital nor the home; it is the mobile phone,” they write. “The surge in patient messages is a clear sign that patients want more access to information about their health, even though wait times and responses are often vague. ” Learn more about their technology-driven proposition and how they hope to create reimbursement models that reward asynchronous care.
AI is appearing in many jobs. What about cancer researchers?
My colleague Angus Chen, who covers cancer at STAT, recently co-founded OpenAI, which suggests that artificial intelligence not only treats cancer, but could one day replace principal investigators. A detailed analysis of Sam Altman’s surprising comments. This is a bold claim, but it has received mixed reviews from cancer researchers. Angus discussed Altman’s vision with Shantanu Singh, a machine learning biologist and co-leader of the Carpenter Singh Lab at the Broad Institute.
“Do these models have the ability to mimic so-called creativity? I think Altman has exceeded expectations so there’s reason to be optimistic, but it’s unclear how much we can extrapolate from that,” Shin said. he said. Read Angus’ Q&A here.
ASTP/ONC Preparing: Annual Meeting This December
Last week, I wrote about Mickey Tripathi. He was responsible for organizing and clarifying the Department of Health and Human Services’ AI strategy, as well as the federal reorganization that led to his office being grouped and rebranded as “ASTP/ONC.” The new agency is announcing the agenda for its annual meeting, to be held in Washington, D.C., this December, with sessions including nursing leadership, health equity and access to patient data, and laboratory interoperability. theme is covered. Please check the agenda here.
what we are reading
Doctor says ChatGPT’s bedside manner is better than his, NYT Why NIH is spending $30 million to fight disability discrimination in health care, STAT FTC to sue in epic antitrust case Wouldn’t rule it out, WKOW
Source link
